Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons

Journal of Virology

Volumn 74, Issue 11, 2000, Pages 4957-4966

  Diamond, Michael S ^a,b   Roberts, T Guy ^a   Edgil, Dianna ^a   Lu, Betty ^a   Ernst, Joel ^b,c   Harris, Eva ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERFERON RECEPTOR; VIRUS ANTIGEN; VIRUS RNA;

ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DENGUE VIRUS; FLOW CYTOMETRY; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRION; VIRUS CELL INTERACTION; VIRUS PLAQUE; VIRUS TITRATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CELL LINE; CRICETINAE; DENGUE VIRUS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERFERON-BETA; K562 CELLS; MICE; TIME FACTORS; TUMOR CELLS, CULTURED; U937 CELLS;

EID: 0034101043     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.11.4957-4966.2000     Document Type: Article

References (50)

1. Balmaseda, A., E. Sandoval, L. Perez, C. M. Gutierrez, and E. Harris. 1999. Application of molecular typing techniques in the 1998 dengue epidemic in Nicaragua. Am. J. Trop. Med. Hyg. 61:893-897.
2. Bielefeldt-Ohmann, H. 1998. Analysis of antibody-independent binding of dengue viruses and dengue virus envelope protein to human myclomonocytic cells and B lymphocytes. Virus Res. 57:63-79.
3. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-gamma, Annu. Rev. Immunol. 15:749-795.
4. Brandt, W. E., J. M. McCown, M. K. Gentry, and P. K. Russell. 1982. Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect. Immun. 36:1036-1041.
5. Chen, Y., T. Maguire, R. E. Hileman, J. R. Fromm, J. D. Esko, R. J. Linhardt, and R. M. Marks. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3:866-871.
6. Elbishbishi, E. A., R. Agarwal, R. Raghupathy, R. Nagar, R. Tandon, A. S. Pacsa, O. I. Younis, and F. Azizieh. 1999. Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures. J. Med. Virol. 59:335-340.
7. English, D., and B. R. Anderson. 1974. Single-step separation of red blood cells, granulocytes, and mononuclear cells on discontinuous density gradients of ficoll-hypaque. J. Immunol. Methods 5:249-253.
8. Gale, M., Jr., and M. G. Katze. 1998. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78:29-46.
9. Green, S., D. W. Vaughn, S. Kalayanarooj, S. Nimmannitya, S. Suntayakorn, A. Nisalak, R. Lew, B. L. Innis, I. Kurane, A. L. Rothman, and F. A. Ennis. 1999. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis. 179:755-762.
10. Guzman, M. G., M. Alvarez, R. Rodriguez, D. Rosario, S. Vazquez, L. Valdés, M. V. Cabrera, and G. Kouri. 1999. Fatal dengue hemorrhagic fever in Cuba, 1997. Int. J. Infect. Dis. 3:130-135.
11. Haberhausen, G., J. Pinsl, C. C. Kuhn, and C. Markert-Hahn. 1998. Comparative study of different standardization concepts in quantitative competitive reverse transcription-PCR assays. J. Clin. Microbiol. 36:628-633.
12. Halstead, S. B. 1989. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev. Infect. Dis. 11(Suppl. 4): S830-S839.
13. Halstead, S. B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481.
14. Halstead, S. B., and E. J. O'Rourke. 1977. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265:739-741.
15. Halstead, S. B., J. S. Porterfield, and E. J. O'Rourke. 1980. Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am. J. Trop. Med. Hyg. 29:638-642.
16. Harinasuta, C., C. Wasi, and S. Vithanomsat. 1984. The effect of interferon on Japanese encephalitis virus in vitro. Southeast Asian J. Trop. Med. Public Health 15:564-568.
17. Harlow, E., and D. Lane. 1988. Antibodies, a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
18. Harris, E., T. G. Roberts, L. Smith, J. Selle, L. D. Kramer, S. Valle, E. Sandoval, and A. Balmaseda. 1998. Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR. J. Clin. Microbiol. 36:2634-2639.
19. Hase, T., P. L. Summers, and K. H. Eckels. 1989. Flavivirus entry into cultured mosquito cells and human peripheral blood monocytes. Arch. Virol. 104:129-143.
20. Hasegawa, H., Y. Satake, and Y. Kobayashi. 1990. Effect of cytokines on Japanese encephalitis virus production by human monocytes. Microbiol. Immunol. 34:459-466.
21. Hoofnagle, J. H. 1994. Therapy of acute and chronic viral hepatitis. Adv. Intern. Med. 39:241-275.
22. Jiang, Y. H., L. A. Davidson, J. R. Lupton, and R. S. Chapkin. 1996. Rapid competitive PCR determination of relative gene expression in limiting tissue samples. Clin. Chem. 42:227-231.
23. Johnson, A. J., and J. T. Roehrig. 1999. New mouse model for dengue virus vaccine testing. J. Virol. 73:783-786.
24. Klimstra, W. B., K. D. Ryman, and R. E. Johnston. 1998. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J. Virol. 72:7357-7366.
25. Kontny, U., I. Kurane, and F. A. Ennis. 1988. Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J. Virol. 62:3928-3933.
26. Kurane, I., and F. A. Ennis. 1987. Induction of interferon alpha from human lymphocytes by autologous, dengue virus-infected monocytes. J. Exp. Med. 166:999-1010.
27. Kurane, I., and F. A. Ennis. 1988. Production of interferon alpha by dengue virus-infected human monocytes. J. Gen. Virol. 69:445-449.
28. Kurane, I., B. L. Innis, C. H. Hoke, Jr., K. H. Eckels, A. Meager, J. Janus, and F. A. Ennis. 1995. T cell activation in vivo by dengue virus infection. J. Clin. Lab. Immunol. 46:35-40.
29. Kurane, I., B. L. Innis, S. Nimmannitya, A. Nisalak, A. Meager, and F. A. Ennis. 1993. High levels of interferon alpha in the sera of children with dengue virus infection. Am. J. Trop. Med. Hyg. 48:222-229.
30. Kurane, I., B. L. Innis, S. Nimmannitya, A. Nisalak, A. Meager, J. Janus, and F. A. Ennis. 1991. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J. Clin. Investig. 88:1473-1480.
31. Kurane, I., B. L. Innis, S. Nimmannitya, A. Nisalak, A. L. Rothman, P. G. Livingston, J. Janus, and F. A. Ennis. 1990. Human immune responses to dengue viruses. Southeast Asian J. Trop. Med. Public Health 21:658-662.
32. Kurane, I., B. L. Innis, A. Nisalak, C. Hoke, S. Nimmannitya, A. Meager, and F. A. Ennis. 1989. Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J. Clin. Investig. 83: 506-513.
33. Kurane, I., J. Janus, and F. A. Ennis. 1992. Dengue virus infection of human skin fibroblasts in vitro production of IFN-beta, IL-6 and GM-CSF. Arch. Virol. 124:21-30.
34. Kurane, I., U. Kontny, J. Janus, and F. A. Ennis. 1990, Dengue-2 virus infection of human mononuclear cell lines and establishment of persistent infections. Arch. Virol. 110:91-101.
35. Kurane, I., A. L. Rothman, P. G. Livingston, S. Green, S. J. Gagnon, J. Janus, B. L. Innis, S. Nimmannitya, A. Nisalak, and F. A. Ennis. 1994 Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch. Virol. Suppl. 9:59-64.
36. Leitmeyer, K. C., D. W. Vaughn, D. M. Watts, R. Salas, I. Villalobos de Chacon, C. Ramos, and R. Rico-Hesse. 1999. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73:4738-4747.
37. Lin, Y. L., Y. L. Huang, S. H. Ma, C. T. Yeh, S. Y. Chiou, L. K. Chen, and C. L. Liao. 1997. Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J. Virol. 71:5227-5235.
38. Lin, Y. L., C. L. Liao, L. K. Chen, C. T. Yeh, C. I. Liu, S. H. Ma, Y. Y. Huang, Y. L. Huang, C. L. Kao, and C. C. King. 1998. Study of dengue virus infection in SCID mice engrafted with human K562 cells. J. Virol. 72:9729-9737.
39. Littaua, R., I. Kurane, and F. A. Ennis. 1990. Human lgG Fc receptor II mediates antibody-dependent enbancement of dengue virus infection. J. Immunol. 144:3183-3186.
40. Monath, T. P. 1994. Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci. USA 91:2395-2400.
41. Pinto, A. J., P. S. Morahan, M. Brinton, D. Stewart, and E. Gavin. 1990. Comparative therapeutic efficacy of recombinant interferons-alpha, -beta, and -gamma against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections. J. Interferon Res. 10:293-298.
42. Platanias, L. C., S. Uddin, P. Domanski, and O. R. Colamonici. 1996. Differences in interferon α and β signalling. J. Biol. Chem. 271:23630-23633.
43. Rico-Hesse, R., L. M. Harrison, A. Nisalak, D. W. Vaughn, S. Kalayanarooj, S. Green, A. L. Rothman, and F. A. Ennis. 1998. Molecular evolution of dengue type 2 virus in Thailand. Am. J. Trop. Med. Hyg. 58:96-101.
44. Rico-Hesse, R., L. M. Harrison, R. A. Salas, D. Tovar, A. Nisalak, C. Ramos, J. Boshell, M. T. de Mesa, R. M. Nogueira, and A. T. da Rosa. 1997. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230:244-251.
45. Rothman, A. L., and F. A. Ennis. 1999. Immunopathogenesis of Dengue hemorrhagic fever. Virology 257:1-6.
46. Russell, P. K., S. Udomsakdi, and S. B. Halstead. 1967. Antibody response in dengue and dengue hemorrhagic fever. Jpn. J. Med. Sci. Biol. 20:103-108.
47. Sittisombut, N., N. Maneekarn, A. Kanjanahaluethai, W. Kasinrerk, K. Viputtikul, and J. Supawadee. 1995. Lack of augmenting effect of interferon-gamma on dengue virus multiplication in human peripheral blood monocytes. J. Med. Virol. 45:43-49.
48. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
49. Vithanomsat, S., C. Wasi, C. Harinasuta, and P. Thongcharoen. 1984. The effect of interferon on flaviviruses in vitro: a preliminary study. Southeast Asian J. Trop. Med. Public Health 15:27-31.
50. Watts, D. M., K. R. Porter, P. Putvatana, B. Vazquez, C. Calampa, C. G. Hayes, and S. B. Halstead. 1999. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet 354: 1431-1434.